Zamboanga City COVID-19 watch: 185th patient becomes 5th fatality | Inquirer News

Zamboanga City COVID-19 watch: 185th patient becomes 5th fatality

/ 07:47 AM June 14, 2020

ZAMBOANGA CITY, Zamboanga del Sur – A 42-year old man tested positive for the coronavirus disease 2019  (COVID-19) hours after he expired in a hospital here Saturday afternoon.

He is the 185th confirmed COVID-19 case in the city and the fifth to succumb to the viral respiratory illness.

The fatality from Barangay Salaan here was admitted at the Mindanao Central Sanitarium on June 10 after he complained of loose bowel movement (LBM) and shortness of breath.

Article continues after this advertisement

Sheila Covarrubias, information officer of the city’s Task Force COVID-19, said the man died of acute kidney injury secondary to severe dehydration on top of chronic kidney disease.

“This time, its a community transmission and he is the fifth COVID-19 mortality in the city,” Covarrubias said.

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, dead, Mindanao, Zamboanga

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.